NCT00065390
- Conditions
- Autoimmune Disease, Autoimmune Diseases, Autoimmune Lymphoproliferative Syndrome, +14 more
- Locations
-
- National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
145 public trials
32 recruiting studies
Lymphoproliferative Disorders trial results
NCT00001438
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +15 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00013689
- Conditions
- Autoimmune Disease, Autoimmune Diseases, Autoimmune Lymphoproliferative Syndrome, +13 more
- Locations
-
- National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States
NCT00002153
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +29 more
- Locations
-
- DEKK - TEC Inc New Orleans, Louisiana, United States
Terminated
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
NCT04601584
- Conditions
- ALL, B-precursor Acute Lymphoblastic Leukemia, GNR-084, +14 more
- Locations
-
- Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
- Almazov National Medical Research Centre Saint Petersburg, Russia
- Pavlov First Saint Petersburg State Medical University Saint Petersburg, Russia